EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Does Xenotransplantation Offer a Large Benefit for Human Patients?

Daniel J Hurst, Christopher Bobier iD

The Thoracic and Cardiovascular Surgeon · 01.06.2024 · 72 (04) · 285

DOI: 10.1055/a-2242-0030 ↗

Kurz gefasst

Leserbrief in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.06.2024. Verfasst von Daniel J Hurst und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, Rowan-Virtua School of Osteopathic Medicine, Stratford, New Jersey, United States. Hauptthemen laut MEDLINE: Transplantation, Heterologous, Heterografts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 3 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transplantation, HeterologousHeterograftsHumansAnimalsTreatment OutcomeGraft SurvivalGraft RejectionRisk Factors

Autor:innen und Institutionen

  • Department of Family Medicine, Rowan-Virtua School of Osteopathic Medicine, Stratford, New Jersey, United States.
  • Department of Theology and Philosophy, Saint Mary's University of Minnesota, Winona, Minnesota, United States.

ORCID-Profile: Christopher Bobier

Zitieren

APA

Hurst, D. J., & Bobier, C. (2024). Does Xenotransplantation Offer a Large Benefit for Human Patients?. The Thoracic and Cardiovascular Surgeon, 72(04), 285. https://doi.org/10.1055/a-2242-0030

Vancouver

Hurst DJ, Bobier C. Does Xenotransplantation Offer a Large Benefit for Human Patients?. The Thoracic and Cardiovascular Surgeon. 2024;72(04):285. doi:10.1055/a-2242-0030

BibTeX
@article{Hurst2024,
  author = {Hurst, Daniel J and Bobier, Christopher},
  title = {Does Xenotransplantation Offer a Large Benefit for Human Patients?},
  journal = {The Thoracic and Cardiovascular Surgeon},
  year = {2024},
  volume = {72},
  number = {04},
  pages = {285},
  doi = {10.1055/a-2242-0030}
}
Kostenlos starten →